Geneva, Switzerland
IPF Partners is a leading alternative financing provider focused on the healthcare sector. IPF Partners invests directly in emerging commercial stage pharma/biotech, medtech, diagnostics and IT healthcare companies. IPF Partners provides customised low- to non-dilutive debt and equity financing to market leading healthcare companies and institutions. The focus is on innovating products at commercial stage with a high potential in attractive market. Typical deal size ranges from €5-20m+ over 3- to 6-year duration.
15
Total Investments
10
Portfolio Companies
-
Exits
3
Industries
General Information
Industries
Finance, Health Care +1
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About IPF Partners
Recent Investments (15)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Post-IPO Debt | •••••• | Mar 2024 | |
| Post-IPO Debt | •••••• | Aug 2022 | |
| Post-IPO Debt | •••••• | Feb 2022 | |
| Series D | •••••• | Aug 2020 | |
| Series C | •••••• | Dec 2018 | |
•••• ••••
|
Post-IPO Debt | •••••• | Sep 2018 |
|
•••• ••••
|
Venture Round | •••••• | Jan 2018 |
|
•••• ••••
|
Venture Round | •••••• | Jan 2018 |
|
•••• ••••
|
Debt Financing | •••••• | Jun 2017 |
|
•••• ••••
|
Debt Financing | •••••• | Oct 2016 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
